Blog
Reflections on our Comprehensive Workshop on Preclinical Drug Discovery (CDD)
Last month, the H3D Foundation in partnership with H3D, Fraunhofer-ITMP and EU OPENSCREEN, with funding from VolkswagenStiftung, hosted A Comprehensive Workshop on Preclinical Drug Discovery (CDD) at the DoubleTree Hilton Hotel in Cape Town. Taking place from 16 to...
World Malaria Day: Supporting African scientists to take the lead
On 25 April, we observe World Malaria Day. The annual initiative was instituted by World Health Organization (WHO) Member States during the World Health Assembly in 2007 and aims to bring global attention to the efforts being made to bring an end to malaria. It also...
World TB Day: H3D Foundation Supports Drug Discovery for African Communities by African Researchers
Every year, on 24 March, we mark World Tuberculosis (TB) Day. An initiative of the World Health Organisation (WHO), the day was instated to raise public awareness about the impact of the disease on global health, as well as its social and economic consequences. The...
H3D Foundation announces the 3rd Annual call for mentors for the Global Health Mentorship program in Drug Discovery and Development
H3D Foundation, who are leading the development of the Grand Challenges Africa Drug Discovery Accelerator (GC ADDA) network which engages more than 40 scientists in nine African countries, today announced that they are expanding the Global Health Mentorship program...
African scientists secure major grant to accelerate drug discovery
A network of world-class scientists across Africa has entered the global drug discovery arena after they secured a US$4.7 million grant from the Bill and Melinda Gates Foundation (BMGF) and the medical research charity LifeArc. Led by scientists from the University...
Prof Kelly Chibale awarded AI2050 Senior Fellowship
Professor Kelly Chibale, H3D Foundation CEO, has been selected as a Schmidt Futures AI2050 Senior Fellow. He is among seven researchers making up the second cohort of fellows who will pursue bold and interdisciplinary research in artificial intelligence (AI) to help...
Partnership Announcement: H3D Foundation joins forces with nuvoteQ
H3D Foundation partners with clinical software developers, nuvoteQ, to strengthen the efforts to attract clinical trials to Africa and boost health innovation on the continent Cape Town/Pretoria – In August 2023, the H3D-Foundation (H3D-F) and nuvoteQ signed an...
Major funding boost to support manufacture of medicines in Sub-Saharan Africa
The H3D Foundation is pleased to announce the award of $721,209 USD in funding from the United States Agency for International Development (USAID) through MATRIX, a USAID project to advance the research and development of innovative HIV prevention products for women....
H3D Foundation signs partnership with APN to build pharmaceutical R&D capacity in Africa
Pharmaceutical research and development (R&D) on the African continent is set for a welcome boost following the signing of a partnership deal between African Pharmaceutical Network (APN), a Pan-African network of pharmaceutical industry professionals, stakeholders...
Global Health Mentorship Programme: Nurturing Scientific Leadership for Africa
On 24 October 2022, the H3D Foundation and CP+ Associates co-hosted a scientific leadership workshop for the mentees and mentors participating in the Global Health Mentorship programme. This programme provides structure and support for formal mentorship between...